Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrins are a large family of heterodimeric transmembrane receptors that mediate cell adhesion to the extracellular matrix (ECM) and facilitate cell–cell interactions. They are composed of alpha (α) and beta (β) subunits and play critical roles in cell adhesion, migration, proliferation, survival, and mechanotransduction. Dysregulation is implicated in diseases such as cancer metastasis, thrombosis, and inflammation. Therapeutic strategies focus on blocking ligand binding or interfering with activation.
Blocking ligand binding sites or interfering with activation/conformational change mechanisms.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin Receptor (N/A).